Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders' Equity

v3.22.4
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Balance at beginning of period (in shares) at Dec. 31, 2019   71,931,000      
Balance at beginning of period at Dec. 31, 2019 $ 414,920 $ 7 $ 529,596 $ (887) $ (113,796)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued pursuant to equity awards, net (in shares)   1,515,000      
Common stock issued pursuant to equity awards, net 3,997   3,997    
Common stock issued for merger, net (in shares)   804,000      
Common stock issued for merger, net 17,080   17,080    
Employee stock purchase plan (in shares)   286,000      
Employee stock purchase plan 3,794   3,794    
Stock-based compensation 47,597   47,597    
Net current period other comprehensive income (loss) 2,322     2,322  
Net income (loss) (98,593)       (98,593)
Balance at end of period (in shares) at Dec. 31, 2020   74,536,000      
Balance at end of period at Dec. 31, 2020 391,117 $ 7 602,064 1,435 (212,389)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued pursuant to equity awards, net (in shares)   2,501,000      
Common stock issued pursuant to equity awards, net $ 14,614 $ 1 14,613    
Repurchase of common stock (in shares) (454,372) (455,000)      
Repurchase of common stock $ (23,548)   (23,548)    
Employee stock purchase plan (in shares)   196,000      
Employee stock purchase plan 4,998   4,998    
Stock-based compensation 59,358   59,358    
Net current period other comprehensive income (loss) 690     690  
Net income (loss) $ 41,969       41,969
Balance at end of period (in shares) at Dec. 31, 2021 76,778,000 76,778,000      
Balance at end of period at Dec. 31, 2021 $ 489,198 $ 8 657,485 2,125 (170,420)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued pursuant to equity awards, net (in shares)   2,391,000      
Common stock issued pursuant to equity awards, net $ 10,252   10,252    
Repurchase of common stock (in shares) (564,449) (564,000)      
Repurchase of common stock $ (31,511)   (31,511)    
Employee stock purchase plan (in shares)   140,000      
Employee stock purchase plan 4,684   4,684    
Stock-based compensation 81,868   81,868    
Net current period other comprehensive income (loss) (3,146)     (3,146)  
Net income (loss) $ 125,040       125,040
Balance at end of period (in shares) at Dec. 31, 2022 78,745,000 78,745,000      
Balance at end of period at Dec. 31, 2022 $ 676,385 $ 8 $ 722,778 $ (1,021) $ (45,380)